[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Davita Healthcare Partners (DVA)

Davita Healthcare Partners (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Are Wall Street Analysts Bullish on DaVita Stock?

With a market cap of $11.7 billion, DaVita Inc. (DVA) provides kidney dialysis and related laboratory services for patients with chronic kidney failure, primarily through outpatient centers. It also offers integrated care, clinical research, physician services, and comprehensive kidney care, including home-based and hospital dialysis options.

Shares of the Denver, Colorado-based company have surpassed the broader market over the past 52 weeks. DVA stock has soared 43.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 21.7%. Moreover, the stock has climbed 62.8% on a YTD basis, compared to SPX's 13.3% rise.

Fundamentals

See More
  • Market Capitalization, $K 11,579,699
  • Shares Outstanding, K 63,800
  • Annual Sales, $ 13,643 M
  • Annual Income, $ 746,800 K
  • EBIT $ 2,838 M
  • EBITDA $ 3,553 M
  • 60-Month Beta 0.88
  • Price/Sales 0.83
  • Price/Cash Flow 8.46
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 33.32% (-0.10%)
  • Historical Volatility 60.02%
  • IV Percentile 33%
  • IV Rank 25.00%
  • IV High 58.93% on 08/04/26
  • IV Low 24.78% on 08/22/25
  • Expected Move (DTE 8) 5.78 (3.18%)
  • Put/Call Vol Ratio 0.27
  • Today's Volume 447
  • Volume Avg (30-Day) 3,676
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 72,902
  • Open Int (30-Day) 55,768
  • Expected Range 175.72 to 187.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $3.78
  • Number of Estimates 2
  • High Estimate $4.02
  • Low Estimate $3.54
  • Prior Year $2.51
  • Growth Rate Est. (year over year) +50.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
176.59 +2.78%
on 08/07/26
247.49 -26.66%
on 08/03/26
-51.30 (-22.04%)
since 07/10/26
3-Month
176.59 +2.78%
on 08/07/26
247.49 -26.66%
on 08/03/26
-19.04 (-9.49%)
since 05/12/26
52-Week
101.00 +79.70%
on 01/14/26
247.49 -26.66%
on 08/03/26
+49.42 (+37.42%)
since 08/12/25

Most Recent Stories

More News
Are Wall Street Analysts Bullish on DaVita Stock?

Though DaVita has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

XLV : 168.44 (+0.26%)
$SPX : 7,748.50 (+0.26%)
DVA : 181.50 (+1.77%)
The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call

The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call

DVA : 181.50 (+1.77%)
Stock Indices Fall from Early Highs and Settle Mixed

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.17%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.83%. September...

AMAT : 548.15 (+4.29%)
B : 41.23 (+2.74%)
ANET : 210.50 (+6.39%)
HL : 18.10 (+1.91%)
CDE : 18.80 (+1.18%)
TXN : 276.59 (-1.65%)
$IUXX : 29,742.60 (+0.74%)
AMGN : 416.18 (+0.45%)
ZNU26 : 108-225 (+0.14%)
SHOP : 150.41 (-1.44%)
COMP : 12.73 (+0.32%)
ESU26 : 7,784.25 (+0.18%)
Stocks Supported by Stellar Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +0.31%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.03%. September E-mini S&P futures...

AMAT : 548.15 (+4.29%)
B : 41.23 (+2.74%)
ANET : 210.50 (+6.39%)
HL : 18.10 (+1.91%)
CDE : 18.80 (+1.18%)
WYNN : 102.97 (-1.74%)
TXN : 276.59 (-1.65%)
$IUXX : 29,742.60 (+0.74%)
AMGN : 416.18 (+0.45%)
ZNU26 : 108-225 (+0.14%)
SHOP : 150.41 (-1.44%)
COMP : 12.73 (+0.32%)
DVA Q2 Deep Dive: Flat Volumes and Policy Transitions Shape Outlook

DVA Q2 Deep Dive: Flat Volumes and Policy Transitions Shape Outlook

DVA : 181.50 (+1.77%)
Strong Earnings Push the S&P 500 to New Record High

The S&P 500 Index ($SPX ) (SPY ) today is up +0.46%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.51%. September E-mini S&P futures...

B : 41.23 (+2.74%)
ANET : 210.50 (+6.39%)
HL : 18.10 (+1.91%)
CDE : 18.80 (+1.18%)
WYNN : 102.97 (-1.74%)
$IUXX : 29,742.60 (+0.74%)
AMGN : 416.18 (+0.45%)
ZNU26 : 108-225 (+0.14%)
SHOP : 150.41 (-1.44%)
COMP : 12.73 (+0.32%)
ESU26 : 7,784.25 (+0.18%)
CDW : 136.67 (+0.96%)
DaVita (NYSE:DVA) Beats Q2 CY2026 Sales Expectations But Stock Drops

DaVita (NYSE:DVA) Beats Q2 CY2026 Sales Expectations But Stock Drops

DVA : 181.50 (+1.77%)
DaVita Inc. 2nd Quarter 2026 Results

DENVER , Aug. 4, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2026.

DVA : 181.50 (+1.77%)
DaVita (DVA) Reports Q2: Everything You Need To Know Ahead Of Earnings

DaVita (DVA) Reports Q2: Everything You Need To Know Ahead Of Earnings

DVA : 181.50 (+1.77%)
DaVita (DVA): Buy, Sell, or Hold Post Q1 Earnings?

DaVita (DVA): Buy, Sell, or Hold Post Q1 Earnings?

DVA : 181.50 (+1.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals...

See More

Key Turning Points

3rd Resistance Point 190.66
2nd Resistance Point 186.97
1st Resistance Point 184.23
Last Price 181.50
1st Support Level 177.81
2nd Support Level 174.12
3rd Support Level 171.38

See More

52-Week High 247.49
Fibonacci 61.8% 191.53
Last Price 181.50
Fibonacci 50% 174.24
Fibonacci 38.2% 156.96
52-Week Low 101.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.